214 related articles for article (PubMed ID: 26519782)
41. One Hundred Years of Colposcopy: Reconciling Its Auschwitz Past.
Lentz SE; Ranta A; Domenichini M; Fusco E; Padula F
Ann Intern Med; 2024 Jun; ():. PubMed ID: 38830224
[TBL] [Abstract][Full Text] [Related]
42. Human Papillomavirus Testing in the Last Cervical Screening Round at Age 60-64 Years: Correction.
Obstet Gynecol; 2022 Mar; 139(3):475. PubMed ID: 35176748
[No Abstract] [Full Text] [Related]
43. The route of science: Labyrinths and algorithms - Inspirations by human papillomavirus testing and cervical cancer.
Uhri M; Önal B
Cytojournal; 2015; 12():24. PubMed ID: 26604977
[No Abstract] [Full Text] [Related]
44. Cervical cancer: screening, diagnosis and staging.
Tsikouras P; Zervoudis S; Manav B; Tomara E; Iatrakis G; Romanidis C; Bothou A; Galazios G
J BUON; 2016; 21(2):320-5. PubMed ID: 27273940
[TBL] [Abstract][Full Text] [Related]
45. Why is it appropriate to recommend human papillomavirus vaccination as cervical cancer prevention?
Bednarczyk RA; Figueroa-Downing D; Ault K
Am J Obstet Gynecol; 2016 Apr; 214(4):490-493. PubMed ID: 26529369
[No Abstract] [Full Text] [Related]
46. Triage of HPV positive women in cervical cancer screening.
Wentzensen N; Schiffman M; Palmer T; Arbyn M
J Clin Virol; 2016 Mar; 76 Suppl 1(Suppl 1):S49-S55. PubMed ID: 26643050
[TBL] [Abstract][Full Text] [Related]
47. Practice Bulletin No. 157: Cervical Cancer Screening and Prevention.
Obstet Gynecol; 2016 Jan; 127(1):e1-e20. PubMed ID: 26695583
[TBL] [Abstract][Full Text] [Related]
48. HPV Update: Vaccination, Screening, and Associated Disease.
McNamara M; Batur P; Walsh JME; Johnson KM
J Gen Intern Med; 2016 Nov; 31(11):1360-1366. PubMed ID: 27184752
[TBL] [Abstract][Full Text] [Related]
49. Cervical cancer screening of HPV vaccinated populations: Cytology, molecular testing, both or none.
El-Zein M; Richardson L; Franco EL
J Clin Virol; 2016 Mar; 76 Suppl 1(Suppl 1):S62-S68. PubMed ID: 26631958
[TBL] [Abstract][Full Text] [Related]
50. HPV testing alone is not as safe as cytology and selective HPV testing: AGAINST: There is powerful evidence for primary cervical screening.
Kitchener H
BJOG; 2016 Jan; 123(1):68. PubMed ID: 26527427
[No Abstract] [Full Text] [Related]
51. HPV testing for primary cervical screening: Laboratory issues and evolving requirements for robust quality assurance.
Carozzi FM; Del Mistro A; Cuschieri K; Frayle H; Sani C; Burroni E
J Clin Virol; 2016 Mar; 76 Suppl 1():S22-S28. PubMed ID: 26669512
[TBL] [Abstract][Full Text] [Related]
52. Cervical cancer.
Cohen PA; Jhingran A; Oaknin A; Denny L
Lancet; 2019 Jan; 393(10167):169-182. PubMed ID: 30638582
[TBL] [Abstract][Full Text] [Related]
53. HPV vaccination to prevent oropharyngeal carcinoma: What can be learned from anogenital vaccination programs?
Takes RP; Wierzbicka M; D'Souza G; Jackowska J; Silver CE; Rodrigo JP; Dikkers FG; Olsen KD; Rinaldo A; Brakenhoff RH; Ferlito A
Oral Oncol; 2015 Dec; 51(12):1057-60. PubMed ID: 26520047
[TBL] [Abstract][Full Text] [Related]
54. Epidemiology and Early Detection of Cervical Cancer.
Hillemanns P; Soergel P; Hertel H; Jentschke M
Oncol Res Treat; 2016; 39(9):501-6. PubMed ID: 27614953
[TBL] [Abstract][Full Text] [Related]
55. The Expanded Impact of Human Papillomavirus Vaccine.
Pahud BA; Ault KA
Infect Dis Clin North Am; 2015 Dec; 29(4):715-24. PubMed ID: 26610422
[TBL] [Abstract][Full Text] [Related]
56. VALGENT: A protocol for clinical validation of human papillomavirus assays.
Arbyn M; Depuydt C; Benoy I; Bogers J; Cuschieri K; Schmitt M; Pawlita M; Geraets D; Heard I; Gheit T; Tommasino M; Poljak M; Bonde J; Quint W
J Clin Virol; 2016 Mar; 76 Suppl 1():S14-S21. PubMed ID: 26522865
[TBL] [Abstract][Full Text] [Related]
57. Global strategies for cervical cancer prevention.
Pimple S; Mishra G; Shastri S
Curr Opin Obstet Gynecol; 2016 Feb; 28(1):4-10. PubMed ID: 26642063
[TBL] [Abstract][Full Text] [Related]
58. Underutilization of cervical cancer prevention services in low and middle income countries: a review of contributing factors.
Chidyaonga-Maseko F; Chirwa ML; Muula AS
Pan Afr Med J; 2015; 21():231. PubMed ID: 26523173
[TBL] [Abstract][Full Text] [Related]
59. Human Papillomavirus and Genital Warts: A Review of the Evidence for the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.
Park IU; Introcaso C; Dunne EF
Clin Infect Dis; 2015 Dec; 61 Suppl 8():S849-55. PubMed ID: 26602622
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
